NeoGenomics (NEO) Tops Q3 EPS by 7c

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $152 million versus the consensus estimate of $141.65 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Worried the AI trade has gone too far? Evercore likes these 4 stocks